Filing Details
- Accession Number:
- 0001209191-23-018223
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-13 17:09:40
- Reporting Period:
- 2023-03-03
- Accepted Time:
- 2023-03-13 17:09:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870312 | Walter Kevin Collins | C/O Lucira Health 1412 62Nd Street Emeryville CA 94608 | Chief Revenue Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-03 | 30,102 | $1.15 | 316,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-07 | 81,717 | $0.48 | 234,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
